OvaScience
Life sciences company focused on the discovery, development and commercialization of treatments for infertility.
Launch date
Employees
Market cap
-
Enterprise valuation
$140—210m (Dealroom.co estimates Mar 2013.)
Boston Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $6.0m | Series A | |
$37.0m | Series B | ||
| N/A | $4.0m | Series C | |
| N/A | $35.0m | Series D | |
| N/A | N/A | IPO | |
* | N/A | $50.0m | Post IPO Equity |
* | N/A | $132m | Post IPO Equity |
| N/A | $53.8m | Post IPO Equity | |
N/A | Acquisition | ||
| Total Funding | $82.0m | ||
Recent News about OvaScience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.